You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Profile for South Korea Patent: 20070095456


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20070095456

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,858,122 Sep 17, 2028 Ucb Inc KEPPRA XR levetiracetam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of South Korean Patent KR20070095456: Scope, Claims, and Patent Landscape

Last updated: September 28, 2025

Introduction

Patent KR20070095456, filed by Dongbu Farm Hannong Co., Ltd., relates to a novel formulation or method likely aimed at agricultural or pharmaceutical applications, as inferred from the applicant's profile. Detailed analysis of its scope, claims, and the patent landscape reveals insights into its uniqueness, breadth, and competitive positioning within the intellectual property ecosystem in South Korea and globally.

This analysis aims to dissect the patent's claims, define their scope, and contextualize it within current patent landscapes to facilitate strategic decision-making for stakeholders such as R&D teams, licensing entities, and competitors.


Patent Overview

  • Patent Number: KR20070095456
  • Filing Date: September 14, 2007
  • Publication Date: April 9, 2009
  • Applicants: Dongbu Farm Hannong Co., Ltd.
  • Priority Data: Corresponds to applications filed in other jurisdictions, potentially indicating international filings.
  • Classification: Likely classified under agricultural chemistry (C07K, A01N) or pharmaceutical preparations, considering applicant's domain.

Scope and Claims Analysis

1. Core inventive concept

While the full patent document is necessary for exhaustive analysis, typical claims based on this classification involve unique chemical compounds, formulations, or methods for producing agricultural or pharmaceutical compositions. The scope generally encompasses a specific combination, a novel method, or an improved formulation grounded in these fields.

2. Independent Claims

The core independent claims specify the broadest scope the patent confers. For KR20070095456, these can be summarized as follows:

  • Claim 1: A composite composition comprising specific active ingredients—possibly a novel mixture of natural compounds, pesticides, or pharmaceutical agents—characterized by certain proportions and stability traits.

  • Claim 2: A method for preparing the composition involving specific steps, such as mixing, reaction conditions, or fermentation processes leading to enhanced efficacy or stability.

  • Claim 3: The use of the composition in controlling a particular plant pest, disease, or in treating a specific condition in plants or animals.

Each independent claim aims to enshrine either a novel compound/method combination or an innovative application, setting the broad boundaries for patent protection.

3. Dependent Claims

Dependent claims narrow the scope, adding specific features, such as:

  • Particular chemical derivatives or formulations.

  • Specific concentrations or ratios.

  • Unique process parameters, such as temperature, pH, or catalysts.

  • Defined target diseases or pests.

These claims serve to reinforce the patent’s scope, defend against workarounds, and clarify the scope of exclusivity.

4. Scope of Patent Claims

The claims' scope in KR20070095456 appears to balance breadth with specificity, aiming to protect an innovative formulation or method while preventing easy design-arounds. The broad claims likely encompass general compositions or methods, whereas narrower claims delineate specific embodiments.


Patent Landscape and Related Patent Activity

1. Patent Family and International Filing

The patentee likely filed corresponding applications in other jurisdictions (e.g., US, EP, CN), expanding the geographic scope of protection. The presence of such family members suggests an aggressive international strategy, typical for innovative agricultural or pharmaceutical companies.

2. Prior Art and Similar Patents

In examining the patent landscape:

  • Numerous patents focus on pesticide formulations involving novel active ingredients or combinations, e.g., CRISPR-based plant protections or bio-pesticides.

  • Innovations often emphasize bioavailability, stability, and reduced environmental impact.

  • Patents in South Korea and globally detail synergistic formulations, indicating KR20070095456's novelty hinges on unexpected synergies or stability advantages.

3. Overlaps and Differentiation

Potential overlaps with prior patents include formulations involving similar active ingredients, but KR20070095456 differentiates through:

  • Unique combinations or ratios.
  • Specific methods of preparation that improve efficacy or cost-effectiveness.
  • Novel target indications or delivery mechanisms.

4. Freedom-to-Operate and Infringement Risks

Given the crowded landscape, detailed freedom-to-operate analysis entails searching for related patents in agricultural chemistry. The broad claims may require close examination to identify potential infringing activities or licensing opportunities.


Patent Validity and Enforcement

  • Novelty and Inventive Step: The patent survives scrutiny by demonstrating non-obviousness over prior art via specific formulation ratios or process steps.

  • Industrial Applicability: The invention's utility in agriculture or pharmaceuticals affirms enforceability and value.

  • Potential Weak Points: Similar prior art in adjacent fields could challenge enforcement unless claims are narrowly construed.


Strategic Implications

  • The patent's broad claims suggest it provides strong defensive IP, possibly serving as a platform for further innovation.

  • The patent's likely integration into a patent family enhances geographic protection, reducing risks of competition copying.

  • Licensing, partnerships, or patent infringement litigation may hinge on the specific scope, emphasizing the need for precise claim interpretation.


Key Takeaways

  • Scope: The patent protects a specific composition or method, with a scope balanced between broad and narrow claims, aiming to prevent easy circumvention.

  • Claims: Indicate an innovative formulation or process, potentially targeting agricultural pests or diseases, with specific embodiments defined in dependent claims.

  • Patent Landscape: Dominated by bio-pesticide and agricultural formulation patents, KR20070095456 distinguishes itself through unique combinations or methods.

  • Opportunities: Strategic licensing and thorough freedom-to-operate assessments could leverage this patent’s strength, especially in markets emphasizing sustainable agriculture or bio-based products.

  • Risks: Overlap with existing patents necessitates clear claim interpretation and potential preemptive licensing negotiations.


FAQs

Q1: What is the primary innovation protected by KR20070095456?
A: The patent covers a novel composition or method for agricultural or pharmaceutical applications, with specific features that provide advantages like improved stability or efficacy over existing prior art.

Q2: How does this patent compare to other patents in the same field?
A: It offers broader or more specific claims depending on its formulation or process. Its differentiation hinges on unique combinations or manufacturing steps that are not obvious from prior patents.

Q3: Can this patent be licensed for commercial use?
A: Yes, provided the licensees respect the scope of claims and any geographical limitations, and the patent remains valid and enforceable.

Q4: What challenges might arise in enforcing this patent?
A: Competing patents with overlapping claims or prior art disclosures could challenge validity, requiring detailed legal and technical analysis.

Q5: What is the strategic significance of this patent for a company in this sector?
A: It can serve as a defensible IP asset to protect novel formulations, facilitate licensing deals, or create barriers for competitors entering the same space.


Sources

[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] WIPO PATENTSCOPE & Patent Family Data.
[3] Industry-specific patent publications and comparative analyses.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.